Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Touchlight Genetics Ltd
Touchlight Genetics Ltd
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
GSK licenses Touchlight's enzymatic dbDNA for optimised mRNA vaccine production
GSK will now have non-exclusive rights to the use of dbDNA for efficient commercial DNA and mRNA production
Manufacturing
Touchlight and LenioBio collaborate to expedite protein development and manufacture
The companies have combined their cell-free protein development and manufacturing capabilities to allow the optimal and rapid production of proteins for vaccinations
Research & Development
Touchlight Genetics and the NPL awarded grant to develop single-stranded genome editing template
The grant will allow the development of mbDNA for genome editing, designed to replace the need for viral vectors
Research & Development
Touchlight’s dbDNA to be used in neoantigen cancer vaccine trial
The dbDNA technology will be used in the development of a non-small cell lung cancer vaccine
Cell & Gene Therapy
Touchlight awarded tender to supply enzymatic dbDNA to CPI
CPI has selected Touchlight to supply research and GMP-grade enzymatic DNA for the development and manufacturing of RNA therapeutics and vaccines
Research & Development
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA)
Manufacturing
Touchlight creates giant London DNA manufacturing facility
Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines
Subscribe now